The studies on the characterization of LM autoantibodies reacting against the hepatic CYP-1A2 regarded essentially adults suffering from hydralazine-induced AIH [17] or children and adults affected by AIH as part of APS-1 [9–16]. The gene discussed is CYP1A2; the disease is autoimmune polyendocrine syndrome type 1.